Assay design is a major factor underpinning the success of any drug discovery programme. A well-designed assay should be one in which every step in the protocol has been evaluated.
One analogy is that assays are like aeroplanes; if you need to travel 500, 5,000 or 50,000 miles, you want to fly in a well-designed aeroplane and get the same outcome every flight: you arrive safely!
Whether built from literature or already existing, our focus is always on ensuring the assay is fit for purpose.
Download our eBook to find out more:
You can also find out more about our assay development service here Assay development in drug discovery - Charnwood Molecular (charnwood-molecular.com)
Our bioscience leadership has decades of large pharma experience in drug discovery gained in companies including Hoffmann La Roche, Smith Kline Beecham, GlaxoWellcome, AstraZeneca, ICI and UCB.
The wider team has worked in pre-clinical discovery, designing and developing low, medium and high throughput assays in both cellular and non-cellular assay formats.
They have experience of a wide range of technologies designed to prosecute these activities in a scalable manner whilst bringing to bear technological developments that have the ability to probe ever further into the molecular interactions from which the drugs of the future may be identified.
A culture of approaching problems as a group results in time efficient and cost effective assay development.